An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease

An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease

ABSTRACT: Objectives: The aim of this study was to determine and compare the efficacy of drugs to treat Mycobacterium kansasii (Mkn) pulmonary disease by performing minimum inhibitory concentration (MIC) determination and time–kill studies. Methods: We determined the MICs to 13 drugs against the Mk...

Full description

Bibliographic Details
Main Authors: Shashikant Srivastava, Jotam G. Pasipanodya, Scott K. Heysell, Gunavanthi D. Boorgula, Tawanda Gumbo, Pamela J. McShane, Julie V. Philley
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Nontuberculous mycobacteria
Mycobacterium kansasii
Repurposed drugs
Efficacy
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716521002848

Internet

http://www.sciencedirect.com/science/article/pii/S2213716521002848

Similar Items